Bin Song, MD, PhD
|
Investigator, Other (M) Neurosurgery, Mass General Research Institute |
|
Member of the Faculty of Neurosurgery Harvard Medical School |
|
Scientific Director The George A. “Doc” Lopez, MD Laboratory for Regenerative Cell Therapy, Massachusetts General Hospital |
Research Narrative
The George A. “Doc” Lopez, MD Laboratory for Regenerative Cell Therapy, situated within the Department of Neurosurgery at Massachusetts General Hospital and led by Bin Song, MD, PhD, Scientific Director, and Jeffrey Schweitzer, MD, PhD, Clinical Director, is an innovative research facility dedicated to advancing neurobiological science.
The mission of The George A. “Doc” Lopez, MD Laboratory for Regenerative Cell Therapyis to pioneer innovative methods for treating Parkinson’s disease and related degenerative disorders of the nervous system at the cellular level. Our focus involves utilizing state-of-the-art tools for cellular reprogramming, gene editing, and directed differentiation of stem cell products. The laboratory is not only dedicated to the development of these novel therapeutic products but is also equipped with its own self-contained Good Manufacturing Practices (GMP) facility. This facility allows us to produce these products at clinical grade, ensuring the highest standards, and supporting early clinical trials in our pursuit of advancing regenerative cell therapy.
| bsong@mgh.harvard.edu |
| (617) 201-8668 |
|
Neurosurgery White Building 55 Fruit Street Room 536 Boston, MA 02114 |